Adjuvant Abemaciclib Plus Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A

Rachel A. Freedman; Stephanie L. Graff; Mark R. Somerfield; Melinda L. Telli; Antonio C. Wolff; Sharon H. Giordano

doi:10.1200/OP.22.00140

Adjuvant Abemaciclib Plus Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A

Rachel A. Freedman, Stephanie L. Graff, Mark R. Somerfield, Melinda L. Telli, Antonio C. Wolff, Sharon H. Giordano

School of Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	516-519
Number of pages	4
Journal	JCO Oncology Practice
Volume	18
Issue number	7
DOIs	https://doi.org/10.1200/OP.22.00140
State	Published - Jul 1 2022

ASJC Scopus subject areas

Oncology
Health Policy
Oncology(nursing)

Access to Document

10.1200/OP.22.00140

Cite this

@article{c8e26aaae4e6489ebbc180575bfac39e,

title = "Adjuvant Abemaciclib Plus Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A",

author = "Freedman, {Rachel A.} and Graff, {Stephanie L.} and Somerfield, {Mark R.} and Telli, {Melinda L.} and Wolff, {Antonio C.} and Giordano, {Sharon H.}",

year = "2022",

month = jul,

day = "1",

doi = "10.1200/OP.22.00140",

language = "English (US)",

volume = "18",

pages = "516--519",

journal = "JCO Oncology Practice",

issn = "2688-1527",

publisher = "American Society of Clinical Oncology",

number = "7",

}

TY - JOUR

T1 - Adjuvant Abemaciclib Plus Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer

T2 - ASCO Guideline Rapid Recommendation Update Q and A

AU - Freedman, Rachel A.

AU - Graff, Stephanie L.

AU - Somerfield, Mark R.

AU - Telli, Melinda L.

AU - Wolff, Antonio C.

AU - Giordano, Sharon H.

PY - 2022/7/1

Y1 - 2022/7/1

UR - http://www.scopus.com/inward/record.url?scp=85134426771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85134426771&partnerID=8YFLogxK

U2 - 10.1200/OP.22.00140

DO - 10.1200/OP.22.00140

M3 - Article

C2 - 35377771

AN - SCOPUS:85134426771

SN - 2688-1527

VL - 18

SP - 516

EP - 519

JO - JCO Oncology Practice

JF - JCO Oncology Practice

IS - 7

ER -

Adjuvant Abemaciclib Plus Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this